Ceapro Inc. (CVE:CZO – Get Free Report) dropped 11.8% during trading on Monday . The company traded as low as C$0.23 and last traded at C$0.23. Approximately 5,850 shares traded hands during trading, a decline of 88% from the average daily volume of 50,562 shares. The stock had previously closed at C$0.26.
Ceapro Stock Down 11.8%
The company has a debt-to-equity ratio of 8.28, a quick ratio of 18.88 and a current ratio of 7.10. The firm has a market cap of C$688,880.00, a price-to-earnings ratio of -2.83 and a beta of 1.38. The business’s 50 day moving average price is C$0.22 and its 200 day moving average price is C$0.23.
About Ceapro
Ceapro Inc, a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.
Featured Articles
- Five stocks we like better than Ceapro
- Why is the Ex-Dividend Date Significant to Investors?
- ServiceNow’s $7 Billion Gamble: Panic or Opportunity?
- What is the Hang Seng index?
- Dell and HP Are Raising Prices—And Investors Should Take Note
- ESG Stocks, What Investors Should Know
- Why DLocal Is the Top Emerging Market Fintech Stock to Watch for 2026
Receive News & Ratings for Ceapro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceapro and related companies with MarketBeat.com's FREE daily email newsletter.
